TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.

TK Modeler 1.0 is a Microsoft® Excel®-based pharmacokinetic (PK) modeling program created to aid in the design of toxicokinetic (TK) studies. TK Modeler 1.0 predicts the diurnal blood/plasma concentrations of a test material after single, multiple bolus or dietary dosing using known PK information. Fluctuations in blood/plasma concentrations based on test material kinetics are calculated using one- or two-compartment PK model equations and the principle of superposition. This information can be utilized for the determination of appropriate dosing regimens based on reaching a specific desired C(max), maintaining steady-state blood/plasma concentrations, or other exposure target. This program can also aid in the selection of sampling times for accurate calculation of AUC(24h) (diurnal area under the blood concentration time curve) using sparse-sampling methodologies (one, two or three samples). This paper describes the construction, use and validation of TK Modeler. TK Modeler accurately predicted blood/plasma concentrations of test materials and provided optimal sampling times for the calculation of AUC(24h) with improved accuracy using sparse-sampling methods. TK Modeler is therefore a validated, unique and simple modeling program that can aid in the design of toxicokinetic studies.

[1]  R. Jochemsen,et al.  Assessment of drug exposure in rat dietary studies. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  A. Ignaszewski,et al.  Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  A. Jeffcoat,et al.  Disposition and Pharmacokinetics of Isopropanol in F-344 Rats and B6C3F1 Mice , 1994 .

[4]  Dale Hattis,et al.  Approaches to Acrylamide Physiologically Based Toxicokinetic Modeling for Exploring Child–adult Dosimetry Differences , 2007, Journal of toxicology and environmental health. Part A.

[5]  James S Bus,et al.  Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. , 2006, Toxicology and applied pharmacology.

[6]  W. T. Berge,et al.  A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results. , 2011, The Annals of occupational hygiene.

[7]  S. Khan,et al.  Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies , 2012, Critical reviews in toxicology.

[8]  A Johnston,et al.  Limited Sampling Strategies for Estimating Cyclosporin Area Under the Concentration–Time Curve: Review of Current Algorithms , 2001, Therapeutic drug monitoring.

[9]  S Haddad,et al.  A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares. , 1996, Toxicology letters.

[10]  Sudhakar M. Pai,et al.  Characterization of AUCs from Sparsely Sampled Populations in Toxicology Studies , 1996, Pharmaceutical Research.

[11]  S. Kawashima,et al.  Membrane permeability and antipyrine absorption in a rat model of ischemic colitis. , 2004, International journal of pharmaceutics.

[12]  Cees Neef,et al.  Optimal Sampling Strategy Development Methodology Using Maximum A Posteriori Bayesian Estimation , 2011, Therapeutic drug monitoring.

[13]  Mary H. H. Ensom,et al.  Beyond Cyclosporine: A Systematic Review of Limited Sampling Strategies for Other Immunosuppressants , 2006, Therapeutic drug monitoring.

[14]  Kim Z Travis,et al.  Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation. , 2012, Regulatory toxicology and pharmacology : RTP.

[15]  Younggil Kwon,et al.  Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists , 2001, Springer US.

[16]  I. Mahmood.  A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics. , 1997, Journal of pharmaceutical sciences.

[17]  Yong Zhang,et al.  PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..

[18]  K. Krishnan,et al.  An Assessment of the Interindividual Variability of Internal Dosimetry during Multi-Route Exposure to Drinking Water Contaminants , 2010, International journal of environmental research and public health.

[19]  J Yuan,et al.  Modeling blood/plasma concentrations in dosed feed and dosed drinking water toxicology studies. , 1993, Toxicology and applied pharmacology.

[20]  D. Barr,et al.  Comparative pharmacokinetics of chlorpyrifos versus its major metabolites following oral administration in the rat. , 2010, Toxicology.

[21]  Claire Terry,et al.  Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use. , 2012, Regulatory toxicology and pharmacology : RTP.

[22]  M. Abou‐Donia,et al.  Pharmacokinetic profile and placental transfer of a single intravenous injection of [14C]chlorpyrifos in pregnant rats , 2002, Archives of Toxicology.

[23]  B. van Ravenzwaay,et al.  Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  A. Anadón,et al.  Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats , 1990, Antimicrobial Agents and Chemotherapy.